Viatris Inc. Files 2024 10-K Report

Ticker: VTRS · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1792044

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Viatris filed its 2024 10-K. All the deets on their financials are in there.

AI Summary

Viatris Inc. filed its 2024 10-K report on February 27, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, formerly known as Upjohn Inc. until October 23, 2019, is based in Canonsburg, PA. Key financial figures and operational details for the period are outlined in this comprehensive filing.

Why It Matters

This 10-K filing provides investors and stakeholders with a detailed overview of Viatris Inc.'s financial health, operational performance, and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Viatris faces inherent risks related to drug development, regulatory approvals, market competition, and patent expirations.

Key Numbers

Key Players & Entities

FAQ

What was Viatris Inc.'s total revenue for the fiscal year ending December 31, 2024?

The filing indicates a value of $1,193,688,749, which appears to be a significant financial metric for the fiscal year 2024.

When was Viatris Inc. formerly known as Upjohn Inc. and when did the name change occur?

Viatris Inc. was formerly known as Upjohn Inc., and the date of the name change was October 23, 2019.

What is the primary business of Viatris Inc. according to its SIC code?

Viatris Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Viatris Inc. headquartered?

Viatris Inc.'s business and mailing address is 1000 Mylan Boulevard, Canonsburg, PA 15317.

On what date was this 10-K filing submitted to the SEC?

This 10-K filing was submitted to the SEC on February 27, 2025.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Viatris Inc (VTRS).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing